HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo M Croce Selected Research

RNA (Ribonucleic Acid)

1/2020Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer.
1/2018Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.
1/2018Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer.
1/2017RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.
8/2015A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
6/2015RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
1/2015Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
1/2014A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.
6/2012Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity.
5/2012Causes and consequences of microRNA dysregulation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlo M Croce Research Topics

Disease

314Neoplasms (Cancer)
01/2022 - 03/2002
56Carcinogenesis
10/2021 - 01/2003
41Leukemia
01/2022 - 11/2003
38B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2019 - 11/2002
36Breast Neoplasms (Breast Cancer)
01/2022 - 03/2003
29Neoplasm Metastasis (Metastasis)
10/2021 - 10/2006
27Lung Neoplasms (Lung Cancer)
01/2020 - 02/2003
18Lymphoma (Lymphomas)
10/2016 - 01/2005
16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 03/2008
15Hepatocellular Carcinoma (Hepatoma)
03/2018 - 07/2007
14Carcinoma (Carcinomatosis)
01/2019 - 03/2002
13Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 08/2005
11Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 08/2007
11Inflammation (Inflammations)
01/2020 - 10/2008
10Esophageal Neoplasms (Esophageal Cancer)
03/2016 - 10/2004
9Prostatic Neoplasms (Prostate Cancer)
02/2021 - 07/2006
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 02/2003
8Triple Negative Breast Neoplasms
01/2020 - 08/2012
8Adenocarcinoma
01/2015 - 05/2004
7Pancreatic Neoplasms (Pancreatic Cancer)
12/2018 - 09/2004
7Glioblastoma (Glioblastoma Multiforme)
01/2017 - 04/2012
7B-Cell Lymphoma (Lymphoma, B Cell)
01/2017 - 09/2005
7Colonic Neoplasms (Colon Cancer)
01/2014 - 06/2006
7Ovarian Neoplasms (Ovarian Cancer)
06/2013 - 02/2003
7Infections
10/2007 - 11/2004
6Esophageal Squamous Cell Carcinoma
10/2017 - 07/2003
6Disease Progression
01/2017 - 10/2005
6Ovarian Epithelial Carcinoma
11/2016 - 09/2007
6Urinary Bladder Neoplasms (Bladder Cancer)
06/2014 - 11/2004
6Chromosome Aberrations (Chromosome Abnormalities)
07/2011 - 05/2007
5Sarcoma (Soft Tissue Sarcoma)
01/2016 - 01/2005
5Liver Neoplasms (Liver Cancer)
09/2012 - 07/2008
5Stomach Neoplasms (Stomach Cancer)
02/2010 - 05/2004
4Cachexia
01/2020 - 03/2014
4Hypoxia (Hypoxemia)
01/2016 - 03/2007
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2013 - 06/2008
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2010 - 06/2005
4Adenoma (Adenomas)
02/2007 - 05/2002
3Melanoma (Melanoma, Malignant)
01/2018 - 01/2016
3Multiple Myeloma
01/2016 - 09/2008
3Inborn Genetic Diseases (Disease, Hereditary)
07/2015 - 09/2007

Drug/Important Bio-Agent (IBA)

248MicroRNAs (MicroRNA)IBA
01/2022 - 11/2002
82Proteins (Proteins, Gene)FDA Link
10/2021 - 07/2002
45Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2003
26Biological ProductsIBA
10/2021 - 03/2003
21Messenger RNA (mRNA)IBA
07/2020 - 04/2003
17DNA (Deoxyribonucleic Acid)IBA
01/2016 - 04/2005
16RNA (Ribonucleic Acid)IBA
01/2020 - 10/2004
14Pharmaceutical PreparationsIBA
01/2022 - 10/2005
14CarcinogensIBA
01/2020 - 09/2003
13ZincIBA
10/2017 - 01/2003
11Histidine (L-Histidine)FDA Link
10/2014 - 03/2002
10WW Domain-Containing OxidoreductaseIBA
01/2020 - 02/2003
10fragile histidine triad proteinIBA
01/2019 - 03/2002
9nitrosobenzylmethylamineIBA
01/2020 - 01/2003
8Phosphotransferases (Kinase)IBA
10/2013 - 05/2007
7Transcription Factors (Transcription Factor)IBA
01/2020 - 11/2004
7Untranslated RNA (Noncoding RNA)IBA
01/2019 - 09/2007
7mouse MIRN29 microRNAIBA
08/2012 - 06/2009
6Transfer RNA (tRNA)IBA
01/2020 - 01/2017
6Caspase 3 (Caspase-3)IBA
12/2018 - 07/2002
6LigandsIBA
01/2018 - 09/2007
6Tyrosine (L-Tyrosine)FDA Link
10/2012 - 04/2005
6OligonucleotidesIBA
09/2012 - 12/2005
6NucleotidesIBA
07/2012 - 11/2003
5Antineoplastic Agents (Antineoplastics)IBA
07/2020 - 09/2010
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 07/2002
5AntigensIBA
01/2018 - 04/2013
5Long Noncoding RNAIBA
01/2018 - 01/2014
5ErbB Receptors (EGF Receptor)IBA
01/2018 - 07/2009
5CaspasesIBA
11/2015 - 10/2004
5Histone Deacetylase InhibitorsIBA
11/2014 - 07/2006
4Small Untranslated RNAIBA
01/2022 - 06/2004
4NucleolinIBA
07/2020 - 05/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 01/2009
4NucleophosminIBA
04/2014 - 03/2008
4MethyltransferasesIBA
06/2013 - 07/2006
4DecitabineFDA Link
02/2013 - 07/2006
4NF-kappa B (NF-kB)IBA
07/2010 - 11/2008
3Receptor Tyrosine Kinase-like Orphan ReceptorsIBA
01/2021 - 01/2014
33' Untranslated Regions (3' UTR)IBA
04/2019 - 12/2008
3Ferredoxins (Ferredoxin)IBA
01/2019 - 05/2008
3Oxidoreductases (Dehydrogenase)IBA
01/2019 - 05/2008
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 05/2008
3PlatinumIBA
12/2018 - 12/2008
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2018 - 06/2015
3EnzymesIBA
10/2017 - 10/2007
3Paclitaxel (Taxol)FDA LinkGeneric
05/2016 - 01/2013
3Peptides (Polypeptides)IBA
05/2016 - 10/2012
3Estrogen Receptor alphaIBA
01/2015 - 05/2010
3Tyrosine Kinase InhibitorsIBA
10/2013 - 07/2009
3ChromatinIBA
10/2013 - 12/2008
3Insulin (Novolin)FDA Link
09/2013 - 07/2005
3trichostatin A (A 300)IBA
02/2013 - 07/2006
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2012 - 01/2010
3Protein Tyrosine PhosphatasesIBA
10/2012 - 06/2006

Therapy/Procedure

72Therapeutics
01/2021 - 05/2002
11Drug Therapy (Chemotherapy)
01/2020 - 05/2007
3Chemoprevention
02/2018 - 05/2006
3Immunotherapy
12/2016 - 10/2016